Phathom Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: Phathom Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Phathom Pharmaceuticals Inc
Rating: 1.96541675
Author: Trendlyne DVM scores

about

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

11.84 -0.22 (-1.82%)

39.93% Fall from 52W High

775.5K

XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.7 / 100

Technically Bullish

71.0 / 100

1Yr Price target upside is 81%

8 analysts

Phathom Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Phathom Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule...

39.93% Fall from 52W High

SWOT Analysis

Phathom Pharmaceuticals Inc Live Price Chart